Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02922751 · ClinicalTrials.gov registry record
FibroScan™ in Pediatric Cholestatic Liver Disease (FORCE)
A clinical trial, sponsored by Arbor Research Collaborative for Health.
- Completed
- Registry status
- 552
- Enrollment target
NCT02922751 is a clinical trial that has completed, run by Arbor Research Collaborative for Health. The registered enrollment target is 552 participants.
The verdict
NCT02922751 has completed, sponsored by Arbor Research Collaborative for Health.
- COMPLETED
- Registry status
- 552 participants
- Enrollment target
Study Summary
Noninvasive monitoring of liver fibrosis is an unmet need within the clinical management of pediatric chronic liver disease. While liver biopsy is often used in the initial diagnostic evaluation, subsequent biopsies are rarely performed because of inherent invasiveness and risks. This study will evaluate the role of non-invasive FibroScan™ technology to detect and quantify liver fibrosis.
Interventions
- OTHER Liver Stiffness Measurement (LSM)
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 552 participants |
| Start Date | 2016-11-16 |
| Est. Completion | 2022-12-22 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT02922751
The ClinicalTrials.gov registry entry for NCT02922751 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 552 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Arbor Research Collaborative for Health, which has 15 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Liver Stiffness Measurement (LSM) is the first listed.
NCT02922751 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT02922751 about?
NCT02922751 is a clinical study titled "FibroScan™ in Pediatric Cholestatic Liver Disease (FORCE)". Noninvasive monitoring of liver fibrosis is an unmet need within the clinical management of pediatric chronic liver disease. While liver biopsy is often used in the initial diagnostic evaluation, subsequent biopsies are rarely performed because of inherent invasiveness and risks. This study will eva...
What is the current status of trial NCT02922751?
This trial is currently completed. The enrollment target is 552 participants. The study started on 2016-11-16. Estimated completion is 2022-12-22.
What interventions are being tested in trial NCT02922751?
The interventions under investigation include: Liver Stiffness Measurement (LSM) (OTHER).
Who is sponsoring clinical trial NCT02922751?
This trial is sponsored by Arbor Research Collaborative for Health, which has 15 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.